Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06586918 · ClinicalTrials.gov registry record
Perfusion Index Parameter
A clinical trial, sponsored by Medtronic - MITG.
- Completed
- Registry status
- 32
- Enrollment target
NCT06586918: Completed study, sponsored by Medtronic - MITG.
NCT06586918 is a clinical trial that has completed, run by Medtronic - MITG. The registered enrollment target is 32 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06586918 has completed, sponsored by Medtronic - MITG.
- COMPLETED
- Registry status
- 32 participants
- Enrollment target
Study Summary
To evaluate the association between the Perfusion index parameter and an independent measure of perfusion.
Primary Outcome
To confirm correlation of Perfusion Index measured by the investigational pulse oximeter PCBA and Market Released sensors to the laser doppler measure of skin perfusion (LDSP) as determined by an overall instantaneous (lag(0)) Spearman rank correlation.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 32 participants |
| Start Date | 2024-09-04 |
| Est. Completion | 2024-09-13 |
What the finished NCT06586918 record still lists
NCT06586918 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 32 participants, a relatively small participant target.
The record links to 0 conditions, and to 0 interventions.
NCT06586918 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT06586918 about?
NCT06586918 is a clinical study titled "Perfusion Index Parameter". To evaluate the association between the Perfusion index parameter and an independent measure of perfusion.
What is the current status of trial NCT06586918?
This trial is currently completed. The enrollment target is 32 participants. The study started on 2024-09-04. Estimated completion is 2024-09-13.
Who is sponsoring clinical trial NCT06586918?
This trial is sponsored by Medtronic - MITG, which has 119 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02445781 · 32 participants · Early Phase 1
Differing Levels of Hypoglycemia
- NCT02792270 · 32 participants · NA
Caloric Restriction In Sarcoma Patients Treated With Pre-Operative RT
- NCT03068910 · 32 participants · Early Phase 1
Hyperandrogenemia and Altered Day-night LH Pulse Patterns
- NCT03208868 · 32 participants · NA
Leucine Enriched Essential Amino Acid Mixture to Reverse Muscle Loss in Cirrhosis
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI